May 2011 Briefing - HIV & AIDSLast Updated: June 01, 2011.
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for May 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Effect Estimates May Be Inflated in Biomarker Studies
TUESDAY, May 31 (HealthDay News) -- Biomarker effects are often overestimated in highly cited studies compared to the effects reported in subsequent meta-analyses of the same associations, according to a review published in the June 1 issue of the Journal of the American Medical Association.
Contact With Drug Industry Linked to Positive Attitudes
WEDNESDAY, May 25 (HealthDay News) -- The extent of contact that medical students have with the pharmaceutical industry is associated with positive attitudes about marketing, according to a review published online May 24 in PLoS Medicine.
Edurant Approved to Treat HIV-1
FRIDAY, May 20 (HealthDay News) -- Edurant (rilpivirine), in combination with other antiretroviral drugs, has been approved by the U.S. Food and Drug Administration to treat HIV-1 infection in adults who haven't taken any prior HIV therapy
Many Medical Students Lack Confidence in Medical Law
FRIDAY, May 20 (HealthDay News) -- The majority of medical students lack confidence in their knowledge and skills across many areas of medical law, according to a study published online May 16 in the Journal of Medical Ethics.
Lower HIV-Related Mortality, Increased Treatment in China
THURSDAY, May 19 (HealthDay News) -- HIV-related mortality has decreased and concomitant treatment coverage has increased in China, but mortality is higher and treatment cover lower in injecting drug users and those infected sexually, according to a study published online May 19 in The Lancet Infectious Diseases.
MRKAd5 Vaccine Found Ineffective Against HIV-1
MONDAY, May 16 (HealthDay News) -- A vaccine tested in a cohort of men and women in South Africa failed to prevent acquisition of HIV-1 or a decrease in viral load in those who acquired the virus, according to research published online May 12 in The Lancet Infectious Diseases.
Early HIV Therapy Reduces Partner's Infection Risk
FRIDAY, May 13 (HealthDay News) -- People with HIV may be able to reduce the risk of transmitting the infection to sexual partners by starting an antiretroviral regimen early, while their immune systems are healthy, according the results of the HPTN 052 trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). The trial was slated to end in 2015, but the findings are being released early after a scheduled interim data review by an independent data and safety monitoring board.
Medical Education Participants Recognize Funding Bias
WEDNESDAY, May 11 (HealthDay News) -- Although most medical professionals believe that commercial funding of continuing medical education (CME) introduces bias, most are not willing to pay higher fees to offset or eliminate such funding sources, according to a study published in the May 9 issue of the Archives of Internal Medicine.
Community Intervention Can Improve HIV Testing Rates
THURSDAY, May 5 (HealthDay News) -- The use of community-based voluntary counseling and testing (CBVCT) appears to improve initial and repeat HIV testing rates in remote communities as compared with standard, clinic-based VCT (SVCT), according to a study published online May 4 in The Lancet Infectious Diseases.
Children Infected With HIV Perinatally Faring Well
MONDAY, May 2 (HealthDay News) -- Most children with perinatal HIV infection are achieving virologic suppression and have normal CD4 lymphocyte counts, according to a study published online March 9 in the Journal of Acquired Immune Deficiency Syndromes.